Bananaquin, developed by Dankonomics Genetics, is an indica/sativa hybrid cannabis strain. This unique strain is a cross between an elite clone of the high-CBD strain Harlequin and Banana Kush F9 male plant. Bananaquin is renowned for its balanced THC and CBD content and can be cultivated in various environments, including indoors, outdoors, and greenhouses. The typical indoor flowering period is around 8-9 weeks, with outdoor plants ready for harvest in late September or early October.
The strain displays a wide range of phenotypes, leading to variations in THC and CBD levels. THC content can range from 7% to 26%, and CBD levels also vary between 6% and 26%. Phenotypes with a higher proportion of CBD tend to be more vigorous and faster-growing, identifiable by a unique smell from the stems when rubbed.
Bananaquin is distinguished by its aroma and taste, characterized by pronounced banana peel notes, strong licorice accents, and a unique new cassette-tape scent. Its effects are typically cerebral and calming, balanced with an underlying indica influence. Medically, it is recommended for a variety of conditions such as seizures, arthritis pain, PTSD, nausea, vomiting, and stress. It is also used in Rick Simpson Oil for cancer patients. The strain's balanced cannabinoid profile makes it suitable for a wide range of medical applications, particularly beneficial for children and dogs due to lower THC and higher CBD phenotypes, while higher THC varieties may be more suitable for cancer patients.